Author

Christoph Holtsträter

Institutions: Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Observed institutions: Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz

OpenAlex ID: A5018000763

Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model

2020 · Barbara Schrörs, Sebastian Boegel, et al. · Frontiers in Oncology · 210

Bioinformatics for Cancer Immunotherapy

2020 · Christoph Holtsträter, Barbara Schrörs, et al. · Methods in molecular biology · 65

Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens

2022 · David Weber, Jonas Ibn-Salem, et al. · Nature Biotechnology · 59

MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression

2023 · Barbara Schrörs, Brett J. Hos, et al. · Frontiers in Immunology · 32

Prediction of tumor-specific splicing from somatic mutations as a source of neoantigen candidates

2024 · Franziska Lang, Patrick Sorn, et al. · Bioinformatics Advances · 8

ArtiFuse—computational validation of fusion gene detection tools without relying on simulated reads

2019 · Patrick Sorn, Christoph Holtsträter, et al. · Bioinformatics · 4

Works count: 6

Citation count: 378

H-index: 5

I10-index: 4